Heart rehab from your couch? study tests Home-Based recovery
NCT ID NCT04938661
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether doing cardiac rehab at home, or a mix of home and clinic sessions, works as well as going to the clinic for all sessions. 206 heart patients participated, using a mobile health platform and home exercise. The goal was to see if flexible options could improve recovery and reduce hospital readmissions.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- mobile health platform and home-based exercise program
- What this could lead to
- If successful, this could offer heart patients more flexible rehab options that are as effective as traditional clinic visits.
- What could go wrong
- This is a completed study with 206 participants, so results are limited in size. Home-based rehab may not suit all patients, and adherence could vary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
206 people
The number who actually took part.
- Started
-
Jul 2021
- Finished
-
Jun 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Own or have reliable access to a smartphone or desktop computer with internet access * Have an email address * Patients who have a history of one of the following; acute myocardial infarction/acute coronary syndrome, stable angina pectoris, percutaneous coronary intervention, or heart failure. * Patients who have undergone a surgical procedure which includes an indication for cardiac rehabilitation (coronary artery bypass surgery, heart valve repair/replacement, or heart transplant) Exclusion Criteria: * Patients referred to cardiac rehab with ventricular assist devices.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute coronary syndrome are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
University of Minnesota
Minneapolis, Minnesota, 55455, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which SGLT2 inhibitor wins? trial pits empagliflozin against dapagliflozin
- Every minute counts: study tracks how delays shape heart attack survival
- Can daily mindful breathing ease heart failure symptoms?
- Tailoring cardiac rehab to each heart: can personalized training speed recovery?
- Stick-On patch aims to catch dangerous heart decline sooner
- Can a smartphone app keep heart failure patients out of the hospital?